CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug injection tested in patients with Tough-to-Treat lymphoma
Disease control TerminatedThis early-stage trial tested a new drug called GEN3017, given as an injection under the skin, for people with advanced Hodgkin and Non-Hodgkin lymphoma that had come back or stopped responding to other treatments. The main goals were to find a safe dose and see how the body hand…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Halted trial tests new hope for lymphoma patients Who've run out of options
Disease control TerminatedThis study aimed to test whether a new immunotherapy drug called tislelizumab works better than standard chemotherapy for people with Hodgkin lymphoma that has returned or stopped responding to previous treatments. The trial was designed to enroll many patients but was stopped ea…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC